Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Yi

Showing results (561-570 of 570) with videos related to

Pageof 57
Sort By:
You have reached the last page of results.This site can display upto 570 results.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|July 26, 2007
[Multi-center phase II clinical trial of humanized anti-epidermal factor receptor monoclonal antibody h-R3 combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma]Xiao-dong Huang, Jun-lin Yi, Li Gao, et al.
Journal of Medicinal Chemistry|September 25, 2007
Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesityJoachim Rudolph, William P Esler, Stephen O'connor, et al.
International Journal of Radiation Oncology, Biology, Physics|May 26, 2025
International Consensus Guideline on Delineation of the Clinical Target Volumes at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version)Shao-Jun Lin, Qiao-Juan Guo, Qin Liu, et al.
Journal of Autoimmunity|December 7, 2019
Metagenomic profiling of the pro-inflammatory gut microbiota in ankylosing spondylitisChen Zhou, Hui Zhao, Xin-Yue Xiao, et al.
BMC Medicine|November 28, 2023
Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter studyTing Liu, Di Dong, Xun Zhao, et al.
Acta Cardiologica Sinica|November 25, 2024
2023 TSOC-TACVPR-TACPAH Consensus Statement of the Rehabilitation on Patients with Pulmonary HypertensionWei-Chun Huang, Yuan-Yang Cheng, Chih-Hsin Hsu, et al.
Geroscience|July 2, 2026
PROMETHEUS clinical trial protocol: tailoring healthy ageing with lifestyle and nutraceuticalsAjla Hodzic Kuerec, Lihuan Guan, Weilan Wang, et al.
Cancer Communications (London, England)|October 26, 2021
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinomaLing-Long Tang, Yu-Pei Chen, Chuan-Ben Chen, et al.
The Lancet. Oncology|September 4, 2025
Target volume delineation of the neck for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlasLing-Long Tang, Cheng-Long Huang, Shao-Jun Lin, et al.
The Lancet. Oncology|September 4, 2025
Primary target volume delineation for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlasLing-Long Tang, Cheng-Long Huang, Shao-Jun Lin, et al.
Pageof 57

Showing results (561-570 of 570) with videos related to

Sort By:
Pageof 57
You have reached the last page of results.This site can display upto 570 results.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|July 26, 2007
[Multi-center phase II clinical trial of humanized anti-epidermal factor receptor monoclonal antibody h-R3 combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma]Xiao-dong Huang, Jun-lin Yi, Li Gao, et al.
Journal of Medicinal Chemistry|September 25, 2007
Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesityJoachim Rudolph, William P Esler, Stephen O'connor, et al.
International Journal of Radiation Oncology, Biology, Physics|May 26, 2025
International Consensus Guideline on Delineation of the Clinical Target Volumes at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version)Shao-Jun Lin, Qiao-Juan Guo, Qin Liu, et al.
Journal of Autoimmunity|December 7, 2019
Metagenomic profiling of the pro-inflammatory gut microbiota in ankylosing spondylitisChen Zhou, Hui Zhao, Xin-Yue Xiao, et al.
BMC Medicine|November 28, 2023
Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter studyTing Liu, Di Dong, Xun Zhao, et al.
Acta Cardiologica Sinica|November 25, 2024
2023 TSOC-TACVPR-TACPAH Consensus Statement of the Rehabilitation on Patients with Pulmonary HypertensionWei-Chun Huang, Yuan-Yang Cheng, Chih-Hsin Hsu, et al.
Geroscience|July 2, 2026
PROMETHEUS clinical trial protocol: tailoring healthy ageing with lifestyle and nutraceuticalsAjla Hodzic Kuerec, Lihuan Guan, Weilan Wang, et al.
Cancer Communications (London, England)|October 26, 2021
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinomaLing-Long Tang, Yu-Pei Chen, Chuan-Ben Chen, et al.
The Lancet. Oncology|September 4, 2025
Target volume delineation of the neck for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlasLing-Long Tang, Cheng-Long Huang, Shao-Jun Lin, et al.
The Lancet. Oncology|September 4, 2025
Primary target volume delineation for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlasLing-Long Tang, Cheng-Long Huang, Shao-Jun Lin, et al.
Pageof 57